Subscribe to this column
Peter Paul Yu, MD, FASCO, FACP
Peter Paul Yu, MD, FACP, FASCO, is the physician-in-chief at Hartford HealthCare Cancer Institute. He is a past president of ASCO, past chair of the Breakthrough Co-Host Committee, and currently serves on the CancerLinQ Board of Governors, as an associate editor of JCO Clinical Cancer Informatics, and on the JCO Oncology Practice editorial board. Follow Dr. Yu on Twitter @YupOnc.
Jun 02, 2014
“Illumination” is a provocative word, evoking as it does the banishment of the darkness of ignorance by the light of new knowledge. Today, we are benefiting from a steady stream of new knowledge about the molecular basis of cancer and the interaction between host and tumor immunology. The concept...
Feb 15, 2014
During the last few months, I have been visiting with as many of the 21 ASCO committees as I can in order to understand the issues that they have identified as most critical for cancer education, research, and patient well being. I have been impressed by the richness of vision and dedication that...
Nov 23, 2013
By chance this week, I experienced a juxtaposition of polar opposites that gave pause for reflection on where we are heading with research that informs advancement in cancer care. For the first two days, I attended the Patient-Centered Outcomes Research Institute (PCORI) Workshop Integrating PROS...
Oct 21, 2013
By my watch, I am somewhere over Lincoln, Nebraska, flying back from the ASCO Provider-Payer Initiative (PPI) Meeting. It’s the third annual PPI meeting and the fact that it exists is significant evidence of ASCO's ability to adapt in response to circumstances and of the increasing resources that...
Oct 14, 2013
There are over 33,000 ASCO members now, and the size and diversity of our membership increases the challenge of keeping the Society in touch with the concerns and opinions that matter the most to our members, the concerns that wake us up in the middle of the night or occupy a good part of our...
Oct 07, 2013
The Atlantic Magazine, together with the University of California San Diego, sponsored a two-day symposium on cancer, highlighting the impact of new technology and drawing upon speakers across the spectrum of the oncology community:...
Latest Blogs